BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8706956)

  • 1. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV).
    Syrjänen KJ
    Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):45-53. PubMed ID: 8706956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
    Cox JT
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
    Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
    Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
    Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
    J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Gynaecol Oncol; 2006; 27(3):215-23. PubMed ID: 16800245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
    J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
    Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
    Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
    Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV, histologic grade and age. Risk factors for the progression of cervical intraepithelial neoplasia.
    Konno R; Paez C; Sato S; Yajima A; Fukao A
    J Reprod Med; 1998 Jul; 43(7):561-6. PubMed ID: 9693405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
    Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
    Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
    Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus Genotype Distribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review.
    Kietpeerakool C; Kleebkaow P; Srisomboon J
    Asian Pac J Cancer Prev; 2015; 16(13):5153-8. PubMed ID: 26225645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
    Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
    J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.